DNA extraction systems for NHS Blood and Transplant come from Qiagen
- NHS Blood and Transplant
- South West
- Call-off from a framework agreement
- 1 November 2025 to 31 October 2027
NHS Blood and Transplant is buying high-throughput DNA extraction systems from Qiagen, with technical support to keep them running.
The contract covers the instruments, their hardware and software, and ongoing maintenance, so the laboratory's diagnostic work carries on without a break. Support comes at manufacturer level for the whole term. The order was placed under a framework agreement.
Qiagen holds the £1,763,731 two-year contract, which runs from November 2025 to October 2027.
Contract ends October 2027
- What
- PCR and molecular diagnostic platforms
- Supplier
- Qiagen
- Value
- £1.76m
- How it was bought
- Call-off from a framework agreement
- Dates and next
- Nov 2025 to Oct 2027